General Information of the Compound
Compound ID
CP0068085
Compound Name
2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide
    Show/Hide
Synonyms
Erivedge (TN)
2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide
2-chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide
2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methylsulfonyl)benzamide
2-chloro-n-(4-chloro-3-(2-pyridinyl)phenyl)-4-(methylsulfonyl)benzamide
25X868M3DS
879085-55-9
AK-77261
C19H14Cl2N2O3S
CHEBI:66903
CHEMBL473417
Erivedge
GDC 0449
GDC-0449
GDC0449
Gdc-0449
HhAntag691
NSC755986
UNII-25X868M3DS
Vismodegib
Vismodegib (GDC-0449)
Vismodegib (SHH inhibitor)
    Show/Hide
Structure
Formula
C19H14Cl2N2O3S
Molecular Weight
421.305
Canonical SMILES
CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(c2)-c2ccccn2)c(Cl)c1
    Show/Hide
InChI
InChI=1S/C19H14Cl2N2O3S/c1-27(25,26)13-6-7-14(17(21)11-13)19(24)23-12-5-8-16(20)15(10-12)18-4-2-3-9-22-18/h2-11H,1H3,(H,23,24)
    Show/Hide
InChIKey
BPQMGSKTAYIVFO-UHFFFAOYSA-N
CAS
879085-55-9
Physicochemical Property
logP
4.7112
Rotatable Bonds
4
Heavy Atom Count
27
Polar Areas
76.13
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 24776445
SID: 49701104
ChEMBL ID
CHEMBL473417
DrugBank ID
DB08828
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02397, Protein smoothened
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
EC50 = 2 nM
   TI
   LI
   LO
   TS
CL000387 C3H/10T1/2 clone 8 Mus musculus (Mouse)  2
1
EC50 = 4.7 nM
   TI
   LI
   LO
   TS
2
IC50 = 5 nM
   TI
   LI
   LO
   TS
CL000035 NIH 3T3 Mus musculus (Mouse)  4
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
2
IC50 = 16 nM
   TI
   LI
   LO
   TS
3
IC50 = 46 nM
   TI
   LI
   LO
   TS
4
IC50 = 400 nM
   TI
   LI
   LO
   TS
CL000426 Shh Light II Mus musculus (Mouse)  1
1
IC50 = 39.2 nM
   TI
   LI
   LO
   TS
Protein ID: PT04361, Protein smoothened
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
EC50 = 3 nM
   TI
   LI
   LO
   TS
CL000006 HEK293 Homo sapiens (Human)  2
1
IC50 = 5.1 nM
   TI
   LI
   LO
   TS
2
IC50 = 7 nM
   TI
   LI
   LO
   TS
CL000426 Shh Light II Mus musculus (Mouse)  1
1
IC50 = 7 nM
   TI
   LI
   LO
   TS
CL000035 NIH 3T3 Mus musculus (Mouse)  1
1
IC50 = 23 nM
   TI
   LI
   LO
   TS
CL000043 U2OS Homo sapiens (Human)  1
1
IC50 = 74 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 EC50 = 2 nM
2 IC50 = 20 nM
3 Kd = 97.5 nM
Protein ID: PT02715, Sonic hedgehog protein
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000035 NIH 3T3 Mus musculus (Mouse)  1
1
IC50 = 7.2 nM
   TI
   LI
   LO
   TS
CL000387 C3H/10T1/2 clone 8 Mus musculus (Mouse)  1
1
IC50 = 13 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000007 HT-29 Homo sapiens (Human)  1
1
IC50 = 1080 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Vismodegib )
Drug Name Vismodegib
Company Genentech
Indication
Basal cell carcinoma
Approved
Primitive neuroectodermal tumour medulloblastoma
Phase 2
Target(s)
Smoothened homolog (SMO)
Modulator